How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Pharmaceutical Sciences industry affect EB-2 NIW petition outcomes?

The Pharmaceutical Sciences sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW)

Postdoctoral Research Associate

Pharmaceutical Sciences · Bangladesh · 2026-01-16

Processing Time

535 days

Decision Date

2026-01-16

Location

Illinois

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The endeavor was found to have national importance due to its focus on identifying molecular targets for more effective cancer therapeutics.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 212 citations demonstrated they are well-positioned to succeed.

3 Balance of Interests Met

USCIS concluded that waiving the labor certification requirement would benefit the United States given the petitioner's specialized expertise.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. and a record of 10 peer-reviewed journal articles and a first-authored abstract. These works accumulated 212 citations, and the petitioner further demonstrated professional standing through 2 completed journal peer reviews. All three Dhanasar prongs were satisfied through evidence of national importance and a strong track record of scholarship.

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Reference Letters Independent

Judging Experience

Original Contributions

Similar Cases

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved

Maryland 470 days 2025-02-28

The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.

View Case

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved

Maryland 26 days 2025-06-02

The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved

Indiana 296 days 2025-02-24

The petitioner proposes to develop targeted cancer therapeutics and precision-based therapeutic options to prevent the recurrence of malignant diseases. The work focuses on creating cost-effective, personalized, and immunological therapies to simplify cancer diagnosis and treatment. The endeavor aims to improve treatment outcomes, reduce side effects, and lower long-term healthcare costs in the United States.

View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved

Texas 296 days 2026-01-14

The petitioner proposes to advance pharmacological research by improving drug-conjugate therapies to create more selective delivery vehicles for cancer treatment. This work focuses on engineering therapeutic payloads to concentrate in tumor cells while limiting exposure to healthy tissue, thereby reducing off-target effects and collateral damage.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Bangladesh

Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-01-16.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 535 days

Criteria Met 3 / 3

Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816

Success Rate 53.6%

Sustained 2,046

Dismissed 1,674

EB-2 (NIW) Overview EB-2 (NIW) in Bangladesh All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Postdoctoral Research Associate

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Evidence

Similar Cases

Research Scientist

Postdoctoral Researcher

Research Scientist

Research Scientist

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights